Overview
Jun-ichirou Yasunaga practices in Kumamoto, Japan. Yasunaga is rated as an Experienced expert by MediFind in the treatment of Pure Red Cell Aplasia. Their top areas of expertise are Adult T-Cell Leukemia, HTLV-1 Associated Myelopathy, Leukemia, Spastic Paraparesis, and Bone Marrow Aspiration.
Their clinical research consists of co-authoring 79 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Pure Red Cell Aplasia.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Adult T-Cell LeukemiaYasunaga isElite. Learn about Adult T-Cell Leukemia.
- Advanced
- HTLV-1 Associated MyelopathyYasunaga isAdvanced. Learn about HTLV-1 Associated Myelopathy.
- LeukemiaYasunaga isAdvanced. Learn about Leukemia.
- Spastic ParaparesisYasunaga isAdvanced. Learn about Spastic Paraparesis.
- Experienced
- Angioimmunoblastic T-cell LymphomaYasunaga isExperienced. Learn about Angioimmunoblastic T-cell Lymphoma.
- B-Cell LymphomaYasunaga isExperienced. Learn about B-Cell Lymphoma.
- Bone Marrow AspirationYasunaga isExperienced. Learn about Bone Marrow Aspiration.
- Follicular LymphomaYasunaga isExperienced. Learn about Follicular Lymphoma.
- LymphadenitisYasunaga isExperienced. Learn about Lymphadenitis.
- Lymphofollicular HyperplasiaYasunaga isExperienced. Learn about Lymphofollicular Hyperplasia.